Noradrenalin Sintetica (Noradrenaline Tartrate)

Norepinephrine, the active ingredient in Noradrenalin Sintetica, is a sympathomimetic vasopressor presented as a sterile solution for injection for intravenous use. It is employed in acute care to raise blood pressure and improve cardiac output in patients with hypotension, cardiac arrest, or septic shock, acting on adrenergic receptors to restore hemodynamic stability.

GNH USA supplies Noradrenalin Sintetica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, intensive care units, emergency departments and pharmacy networks worldwide, ensuring quality‑controlled product availability for critical care environments.

Noradrenalin Sintetica (norepinephrine) is a vasopressor used in the management of severe hypotensive states.

- Hypotension: restores arterial pressure by vasoconstriction, improving organ perfusion. - Cardiac arrest: supports coronary and cerebral perfusion during resuscitation efforts. - Septic shock: counteracts vasodilatory shock to maintain adequate blood pressure.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Tachycardia: increased heart rate due to beta‑1 stimulation. - Headache: result of rapid blood pressure changes. - Anxiety or restlessness: central adrenergic effects. - Nausea: gastrointestinal upset. - Peripheral ischemia: reduced blood flow to extremities.

Serious or Rare Side Effects: - Severe hypertension: excessive vasoconstriction leading to dangerously high blood pressure. - Myocardial ischemia: reduced coronary perfusion causing chest pain or infarction. - Life‑threatening arrhythmias: ventricular tachycardia or fibrillation. - Tissue necrosis at injection site: extravasation causing local damage. - Pulmonary edema: fluid accumulation due to increased afterload.

Use requires careful monitoring and adherence to safety measures.

- Blood pressure monitoring: adjust infusion to maintain target MAP. - Cardiac monitoring: watch for arrhythmias and ischemia. - Dose titration: increase gradually to avoid abrupt hypertension. - Extravasation risk: administer through a central line when possible. - Contraindications: avoid in patients with known hypersensitivity or uncontrolled peripheral ischemia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine may interact with other agents affecting cardiovascular tone.

Major Interactions (Avoid): - MAO inhibitors: can potentiate hypertensive response. - Tricyclic antidepressants: increase risk of severe hypertension. - Beta‑blockers: may blunt desired cardiac effects.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may reduce efficacy of norepinephrine. - ACE inhibitors or ARBs: can alter blood pressure response. - Other vasopressors: additive effects may cause excessive vasoconstriction.